Candi Aesthetics And Consulting

02/06/2026

02/05/2026

02/05/2026

Shelf toxin ≠ a discount problem.
It’s a strategy problem.

If neurotoxin is sitting on your shelf, it’s time to stop cutting prices and start moving inventory intentionally — through bundling, memberships, events, and better patient education.

This is how profitable medspas protect their brand and their margins.

—
Candi Consults Beauty

02/04/2026

01/27/2026

Industry leadership updates always matter. Congratulations to Erick Brenner on his appointment as CEO of Prollenium® Medical Technologies. His experience in global aesthetics and medical dermatology reflects the continued evolution and momentum across our industry.

Strong leadership drives innovation, raises standards, and ultimately benefits providers and patients alike.

01/25/2026

Most practices don’t lose patients because of price.
They lose them because there was no plan.

The highest-converting consults don’t rush decisions.
They create clarity, document options, and build a reason to return.

If a patient can’t do everything today,
are you giving them a roadmap for tomorrow?

Save this as a reminder:
👉 The consult is where practices are built — or lost.

—

01/24/2026

Bad weather doesn’t have to derail your day.

When cancellations spike, it’s rarely about the forecast — it’s about the systems behind your schedule.

Strong confirmation workflows, flexible rescheduling, and clear expectations protect revenue no matter the season.

If no-shows are becoming routine, it’s time to look deeper than the weather.

—
Candi Consults Beauty

01/23/2026

🎙️ Industry Insight Spotlight

In a recent joint conversation, Erik Haines, Head of Guidepoint Qsight, sat down with Benjamin Hernandez of Skytale Group to discuss the latest data shaping the future of aesthetics.

Key takeaway: Neurotoxins remain a cornerstone of practice growth, with the category up 8%, driven by recurring maintenance cycles and strong patient retention.

Data-backed strategy. Sustainable growth.
This is how modern practices scale.

01/21/2026

💕 MEDSPA PROMO IDEAS | Valentine’s Edition 💕

Valentine’s Day isn’t just about romance — it’s about retention, gifting, and intentional self-care.

💘 Treat Yourself
Membership bonuses + skincare perks drive long-term loyalty.

💑 Couples & Besties
Bundled experiences = higher booking value + built-in referrals.

🎁 Share the Love
Gift cards with added value keep patients coming back after February.

Smart promotions don’t discount your brand — they elevate it.
Save this post and plan ahead 💡

✨ Need help customizing Valentine’s promos for your practice?
DM “VALENTINE” 💌

01/17/2026

Other 2016 Mentions to Note:

FDA approval of Juvéderm Volbella XC introduced softer, more natural lip and perioral filler results.

Restylane Refyne and Defyne launched in the U.S., bringing flexible, expression-friendly filler technology.

CoolSculpting CoolAdvantage applicators launched, reducing treatment times and improving patient comfort.

SculpSure expanded adoption as a laser-based, non-invasive body contouring alternative.

Kybella entered widespread clinical use, normalizing injectable fat reduction.

Non-invasive aesthetic procedures continued to outpace surgical procedures in growth.

Facial rejuvenation began to be discussed more holistically, shifting from single treatments to full-face planning.

Lip augmentation trends moved toward natural, hydrated, and subtle enhancement rather than over-volumization.

Microneedling became a mainstream treatment and a staple in combination protocols.

Combination treatment planning (toxins, fillers, energy-based devices) became standard of care.

Direct-to-consumer aesthetic marketing significantly increased patient self-referrals.

Male aesthetics and preventative treatments for younger patients continued to rise.

Early digital consultation and patient engagement tools began shaping modern medspa workflows.

SkinSpirit changed sampling policies, impacting how injectables and skincare were introduced to providers.

In California, aesthetic practices increasingly operated under medical models, requiring physician attachment and more physician-led oversight.